203 related articles for article (PubMed ID: 38270915)
1. Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis.
Singhal S; Rao AS; Stadanlick J; Bruns K; Sullivan NT; Bermudez A; Honig-Frand A; Krouse R; Arambepola S; Guo E; Moon EK; Georgiou G; Valerius T; Albelda SM; Eruslanov EB
Cancer Res; 2024 Apr; 84(7):1029-1047. PubMed ID: 38270915
[TBL] [Abstract][Full Text] [Related]
2. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
Braster R; O'Toole T; van Egmond M
Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors.
Wingert S; Reusch U; Knackmuss S; Kluge M; Damrat M; Pahl J; Schniegler-Mattox U; Mueller T; Fucek I; Ellwanger K; Tesar M; Haneke T; Koch J; Treder M; Fischer W; Rajkovic E
MAbs; 2021; 13(1):1950264. PubMed ID: 34325617
[TBL] [Abstract][Full Text] [Related]
4. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
[TBL] [Abstract][Full Text] [Related]
5. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.
Deo YM; Sundarapandiyan K; Keler T; Wallace PK; Graziano RF
J Immunol; 1998 Feb; 160(4):1677-86. PubMed ID: 9469424
[TBL] [Abstract][Full Text] [Related]
6. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
Front Immunol; 2019; 10():704. PubMed ID: 31031746
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages.
Keler T; Wallace PK; Vitale LA; Russoniello C; Sundarapandiyan K; Graziano RF; Deo YM
J Immunol; 2000 Jun; 164(11):5746-52. PubMed ID: 10820252
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils as immune effector cells in antibody therapy in cancer.
Behrens LM; van Egmond M; van den Berg TK
Immunol Rev; 2023 Mar; 314(1):280-301. PubMed ID: 36331258
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
Brandsma AM; Ten Broeke T; Nederend M; Meulenbroek LA; van Tetering G; Meyer S; Jansen JH; Beltrán Buitrago MA; Nagelkerke SQ; Németh I; Ubink R; Rouwendal G; Lohse S; Valerius T; Leusen JH; Boross P
Cancer Immunol Res; 2015 Dec; 3(12):1316-24. PubMed ID: 26407589
[TBL] [Abstract][Full Text] [Related]
11. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
[TBL] [Abstract][Full Text] [Related]
12. The functional properties of Fc gamma RI, II and III on myeloid cells: a comparative study of killing of erythrocytes and tumor cells mediated through the different Fc receptors.
Shen L; Graziano RF; Fanger MW
Mol Immunol; 1989 Oct; 26(10):959-69. PubMed ID: 2531842
[TBL] [Abstract][Full Text] [Related]
13. Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies.
Valgardsdottir R; Cattaneo I; Klein C; Introna M; Figliuzzi M; Golay J
Blood; 2017 May; 129(19):2636-2644. PubMed ID: 28288980
[TBL] [Abstract][Full Text] [Related]
14. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
van Rees DJ; Bouti P; Klein B; Verkuijlen PJH; van Houdt M; Schornagel K; Tool ATJ; Venet D; Sotiriou C; El-Abed S; Izquierdo M; Guillaume S; Saura C; Di Cosimo S; Huober J; Roylance R; Kim SB; Kuijpers TW; van Bruggen R; van den Berg TK; Matlung HL
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728876
[TBL] [Abstract][Full Text] [Related]
15. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii.
Erbe DV; Pfefferkorn ER; Fanger MW
J Immunol; 1991 May; 146(9):3145-51. PubMed ID: 1826707
[TBL] [Abstract][Full Text] [Related]
16. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.
Li B; Xu L; Tao F; Xie K; Wu Z; Li Y; Li J; Chen K; Pi C; Mendelsohn A; Larrick JW; Gu H; Fang J
Oncotarget; 2017 Jun; 8(24):39356-39366. PubMed ID: 28454118
[TBL] [Abstract][Full Text] [Related]
18. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors.
Otten MA; Rudolph E; Dechant M; Tuk CW; Reijmers RM; Beelen RH; van de Winkel JG; van Egmond M
J Immunol; 2005 May; 174(9):5472-80. PubMed ID: 15843545
[TBL] [Abstract][Full Text] [Related]
19. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells.
Velmurugan R; Challa DK; Ram S; Ober RJ; Ward ES
Mol Cancer Ther; 2016 Aug; 15(8):1879-89. PubMed ID: 27226489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
